LGC

Teddington, United Kingdom Founded: 1842 • Age: 184 yrs Acquired By Astorg Partners
Molecular biology reagents and services are supplied to biotech industries.
Annual revenue $191.0M Latest available
Total funding - 16 rounds
Employees 901 Tracked headcount
Investors 7 Known backers
Products 3 Services tracked
Competitors 10 Brand Intelligence

About LGC

LGC is a company based in Teddington (United Kingdom) founded in 1842 was acquired by Astorg Partners in November 2019. The company has 901 employees as of March 31, 2024. LGC has completed 14 acquisitions, including BRCGS, BioAutomation and Douglas Scientific. LGC offers products and services including KASP Technology, AccuPlex Monkeypox Reference Material Kit, and Reference Materials for PFAS. LGC operates in a competitive market with competitors including Horizon Discovery, Quanterix, Neogen, NanoString and Arrakis Therapeutics, among others.

  • Headquarter Teddington, United Kingdom
  • Employees 901 as on 31 Mar, 2024
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Lgc Limited
  • Date of Incorporation 18 Nov, 1994
  • Jurisdiction MIDDLESEX
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $191.02 M (USD)
    7
    as on Mar 31, 2024
  • Net Profit
    $9.94 M (USD)
    -63
    as on Mar 31, 2024
  • EBITDA
    $9.01 M (USD)
    -69
    as on Mar 31, 2024
  • Latest Funding Round
    $67.55 K (USD), Grant

    Dec 15, 2021

  • Investors
    KKR

    & 6 more

  • Employee Count
    901

    as on Mar 31, 2024

  • Investments & Acquisitions
    BRCGS

    & 13 more

  • Acquired by
    Astorg Partners

    & 2 more

    (Nov 21, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of LGC

LGC offers a comprehensive portfolio of products and services, including KASP Technology, AccuPlex Monkeypox Reference Material Kit, and Reference Materials for PFAS.

Product name locked
Category locked
Primary

Enables precise DNA analysis for conservation and agriculture research.

Product name locked
Category locked
Locked

Supports assay development for disease detection and quality control.

Product name locked
Category locked
Locked

Facilitates accurate chemical analysis in environmental and food safety.

People of LGC

Headcount 1000-5000
Employee Profiles 11
Board Members and Advisors 8
Employee Profiles
People
Bharathi Anekella
EVP, Diagnostics & Genomics Innovation Hub
People
Joydeep Goswami
President & CEO
People
Sanjeev Rana
SVP, Corporate Strategy, Development & Communications
People
Julie Cormack
Chief People Officer

Unlock access to complete

Board Members and Advisors
people
James Davis
Non Executive Director
people
Matthew Norton
Non Executive Director
people
Supraj Rajagopalan
Non Executive Director
people
Tish S Creasey
Non Executive Director

Unlock access to complete

Funding Insights of LGC

Investors in LGC

LGC has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include KKR, HHS and Bridgepoint Capital.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private equity investments and portfolio management services are provided by Cinven across various sectors.
Locked Locked Locked
Multiple sectors are invested in by this private equity firm.
Locked Locked Locked
Astorg is engaged in private equity investment management.
Locked Locked Locked
Premium access

Investor details for LGC

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by LGC

LGC has strategically engaged in corporate development activities, having acquired 14 companies. Notable acquisitions include BRCGS, BioAutomation and Douglas Scientific.

Investments
Premium access

Investment portfolio details for LGC

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Standards and controls for urinalysis testing are developed and manufactured.
Locked Locked 2012 Locked
DNA sequencing services are provided for crop and livestock improvement.
Locked Locked 2011 Locked
Sports services are provided by HFL Sports Group in Prague.
Locked Locked 2010 Locked
Premium access

Complete acquisition details for LGC

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - LGC

Premium access

Detailed financials for LGC

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Lgc Comparisons

LGC Primary company
Description
Molecular biology reagents and services are supplied to biot...
Location
Teddington, United Kingdom
Founded Year
1842
Annual Revenue
$191.02 M (USD)
Net Profit
$9.94 M (USD)
EBITDA
$9.01 M (USD)
Employees
901
As of 2024
Premium access

Peer comparison for LGC

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of LGC

LGC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Horizon Discovery, Quanterix, Neogen, NanoString and Arrakis Therapeutics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Genetically modified cell lines are developed using AAV gene-editing platform.
Locked Locked Locked
Assay kits for ultra-sensitive biomarker detection are developed.
Locked Locked Locked
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
Locked Locked Locked
Tools for translational research and molecular diagnosis are developed.
Locked Locked Locked
Provider of tools for the analysis of RNA structures
Premium access

Detailed competitors of LGC

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Lgc

Premium access

Complete news archive for LGC

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about LGC

LGC was founded in 1842 and raised its 1st funding round 167 years after it was founded.

LGC is headquartered in Teddington, United Kingdom. It is registered at Teddington, Greater London, United Kingdom.

As of Mar 31, 2024, the latest employee count at LGC is 901.

Annual revenue of LGC is $191.02M as on Mar 31, 2024.

LGC was founded in 1842 and is based in Teddington, United Kingdom, where biological testing and research services are provided to biotechnology and pharmaceutical sectors. Operations include DNARNA extraction, genotyping, DNA sequencing, drugs and alcohol testing, forensic analysis, and food and agricultural product evaluation. Reference materials, proficiency testing, genomic products, and lab management solutions are also offered alongside analytical instruments.

LGC's top competitors include Horizon Discovery, Neogen and NanoString.

LGC offers KASP Technology, AccuPlex Monkeypox Reference Material Kit, and Reference Materials for PFAS.

LGC has made 14 acquisitions, including BRCGS, BioAutomation, and Douglas Scientific.

LGC has 7 investors. Key investors include KKR, HHS, Bridgepoint Capital, European Union, and Abu Dhabi Investment Authority.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available